Investor Presentaiton
Innovative testing technologies developed in 2020 (1/2)
* eurofins
•
We believe we are uniquely positioned to derive new scientific meaning for years to come. We have:
O
✓ Capabilities in Environment, Food, Pharma and Clinical, reinforcing each other
✓ A unique fully digitised hub and spoke laboratory infrastructure
✓ One of the world's largest and most varied proprietary databases (biomarkers, DNA, drugs etc.)
✓ A pool of incredibly talented, motivated employees sharing the same vision, Testing for Life
✓ A decentralised entrepreneurial structure that demonstrates exceptional agility and speed of innovation
Laboratories of the Group continued to make advances and innovations in multiple core business areas:
BioPharmaceutical Testing Services
✓ Patented process to eliminate donor variability in Antibody-Dependent Cell-Mediated Cytotoxicity assays
✓ OncoPanel™ Cell-Based Profiling Service, with 300+ genomically-diverse human cancer cell lines
Eurofins Technologies
✓ World's first AOAC Performance Tested Methods SM status for a screening method to detect aflatoxin M1
in milk commodities
11View entire presentation